NEW YORK – IsoPlexis said on Tuesday that it has signed an exclusive agreement with Medquest to distribute IsoPlexis' products in Singapore and Malaysia.
Financial terms of the agreement were not disclosed.
Based in Branford, Connecticut, IsoPlexis markets products for single-cell proteomics research, including the IsoLight System, an automated platform for comprehensive functional protein and metabolite profiling of single cells.